首页> 美国卫生研究院文献>ClinicoEconomics and Outcomes Research: CEOR >Cost-effectiveness analysis of voriconazole fluconazole and amphotericin B for invasive fungal infections following allogeneic hematopoietic stem cell transplantation in Mexico

【2h】

Cost-effectiveness analysis of voriconazole fluconazole and amphotericin B for invasive fungal infections following allogeneic hematopoietic stem cell transplantation in Mexico

机译：伏立康唑氟康唑和两性霉素B在墨西哥同种异体造血干细胞移植后用于侵袭性真菌感染的成本效益分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

BackgroundPatients receiving allogeneic hematopoietic stem cell transplantation (alloHSCT) are at high risk of invasive fungal infections (IFIs), which are associated with high mortality and economic burden. The cost-effectiveness of prophylaxis for the prevention of IFIs in alloHSCT recipients in Mexico has not yet been assessed.

机译：背景技术接受同种异体造血干细胞移植（alloHSCT）的患者处于侵入性真菌感染（IFI）的高风险中，与高死亡率和经济负担相关。尚未评估在墨西哥的alloHSCT接受者中预防IFI的预防的成本效益。

著录项

期刊名称 ClinicoEconomics and Outcomes Research: CEOR
作者
Rayo Morfín-Otero; Martha Alvarado-Ibarra; Eduardo Rodriguez-Noriega; Jesus Resendiz-Sanchez; Dipen A Patel; Jennifer M Stephens; Manuela Di Fusco; Carlos F Mendoza; Claudie Charbonneau;
展开▼
作者单位

展开▼
年(卷),期 2018(10),-1
年度 2018
页码 511–520
总页数 10
原文格式 PDF
正文语种
中图分类
关键词
allogeneic hematopoietic stem cell transplantation triazole invasive aspergillosis invasive candidiasis incremental cost-effectiveness ratio prophylaxis;

机译：同种异体造血干细胞移植;三唑;侵袭性曲霉病;侵袭性念珠菌病;成本效益比增加;预防;

相似文献

外文文献
中文文献
专利

1. Cost-effectiveness analysis of voriconazole, fluconazole, and amphotericin B for invasive fungal infections following allogeneic hematopoietic stem cell transplantation in Mexico [J] . Rayo Morfín-Otero, Martha Alvarado-Ibarra, Eduardo Rodriguez-Noriega, ClinicoEconomics and Outcomes Research . 2018,第3期

机译：伏立康唑，氟康唑和两性霉素B在墨西哥同种异体造血干细胞移植后用于侵袭性真菌感染的成本效益分析
2. Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation. [J] . Wingard JR, Carter SL, Walsh TJ, Blood: The Journal of the American Society of Hematology . 2010,第24期

机译：氟康唑与伏立康唑预防异基因造血细胞移植后侵袭性真菌感染的随机，双盲试验。
3. Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea. [J] . Sohn HS, Lee TJ, Kim J Clinical therapeutics . 2009,第5期

机译：米卡芬净与氟康唑对韩国造血干细胞移植患者预防侵袭性真菌感染的成本效益分析。
4. Circulating Tumor DNA Predicts Post-Allogeneic Hematopoietic Stem Cell Transplantation in AML and MDS [C] . Sousuke Nakamura International Molecular Medicine Tri-Conference. . 2019

机译：循环肿瘤DNA预测AML和MDS中的同种异体造血干细胞移植
5. Invasive fungal infections in the pediatric hematopoietic stem cell transplant recipient. [D] . Chawla, Rupesh. 2006

机译：小儿造血干细胞移植受者的侵袭性真菌感染。
6. Cost-effectiveness Analysis of Voriconazole Compared With Fluconazole for Prevention of Invasive Fungal Infection in Patients Receiving Allogeneic Hematopoietic Cell Transplants [O] . Josephine Mauskopf, Costel Chirila, Jon Graham, -1

机译：伏立康唑和氟康唑相比接受异基因造血细胞移植患者预防侵袭性真菌感染的成本效益分析
7. Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation [O] . Wingard, John R., Carter, Shelly L., Walsh, Thomas J., 2010

机译：氟康唑与伏立康唑预防异基因造血细胞移植后侵袭性真菌感染的随机，双盲试验

Cost-effectiveness analysis of voriconazole fluconazole and amphotericin B for invasive fungal infections following allogeneic hematopoietic stem cell transplantation in Mexico

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅